Literature DB >> 26626125

Alternative methods for the replacement of eye irritation testing.

Christian Lotz1, Freia F Schmid2, Angela Rossi1,2, Szymon Kurdyn1, Daniel Kampik3, Bart De Wever4, Heike Walles1,2, Florian K Groeber2.   

Abstract

In the last decades significant regulatory attempts were made to replace, refine and reduce animal testing to assess the risk of consumer products for the human eye. As the original in vivo Draize eye test has been criticized for limited predictivity, costs and ethical issues, several animal-free test methods have been developed to categorize substances according to the global harmonized system (GHS) for eye irritation.This review summarizes the progress of alternative test methods for the assessment of eye irritation. Based on the corneal anatomy and the current knowledge of the mechanisms causing eye irritation, different ex vivo and in vitro methods will be presented and discussed in regard of possible limitations and their status of regulatory acceptance. In addition to established in vitro models, this review will also highlight emerging, full thickness cornea models that might be applicable to predict all GHS categories.

Entities:  

Keywords:  Draize eye test; OECD guideline; corneal equivalent; eye irritation

Mesh:

Substances:

Year:  2015        PMID: 26626125     DOI: 10.14573/altex.1508241

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  8 in total

Review 1.  In vitro reconstructed 3D corneal tissue models for ocular toxicology and ophthalmic drug development.

Authors:  Yulia Kaluzhny; Mitchell Klausner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-02-05       Impact factor: 2.416

Review 2.  Development of an adverse outcome pathway network for breast cancer: a comprehensive representation of the pathogenesis, complexity and diversity of the disease.

Authors:  Gigly G Del'haye; Ine Nulmans; Sandrine P Bouteille; Karolien Sermon; Brecht Wellekens; Matthias Rombaut; Tamara Vanhaecke; Yvan Vander Heyden; Joery De Kock
Journal:  Arch Toxicol       Date:  2022-08-04       Impact factor: 6.168

3.  Validation of the OptiSafe™ eye irritation test.

Authors:  Neepa Choksi; Stewart Lebrun; Minh Nguyen; Amber Daniel; George DeGeorge; Jamin Willoughby; Adrienne Layton; Donnie Lowther; Jill Merrill; Joanna Matheson; João Barroso; Krystle Yozzo; Warren Casey; David Allen
Journal:  Cutan Ocul Toxicol       Date:  2020-07-16       Impact factor: 1.820

4.  Safety and Tolerability of Overdosed Artificial Tears by Abraded Rabbit Corneas.

Authors:  Philippe Daull; Elisabeth Raymond; Laurence Feraille; Jean-Sébastien Garrigue
Journal:  J Ocul Pharmacol Ther       Date:  2018-10-12       Impact factor: 2.671

5.  Efficacy and local irritation evaluation of Eriobotrya japonica leaf ethanol extract.

Authors:  Nak-Won Seong; Won-Jun Oh; Il-Soo Kim; Su-Jin Kim; Ji-Eun Seo; Chang-Eon Park; Da-Young Kim; Je-Won Ko; Jong-Choon Kim
Journal:  Lab Anim Res       Date:  2019-06-24

Review 6.  Tissue Models for Neisseria gonorrhoeae Research-From 2D to 3D.

Authors:  Motaharehsadat Heydarian; Eva Rühl; Ravisha Rawal; Vera Kozjak-Pavlovic
Journal:  Front Cell Infect Microbiol       Date:  2022-02-11       Impact factor: 5.293

7.  In Vitro Toxicity Evaluation of New Generic Latanost® and Latacom® as an Ophthalmic Formulation.

Authors:  Jessica Sze Chia Ng; Yi Xin Tan; Nor Amalina Ahmad Alwi; Kar Ming Yee; Ahmad Hazri Abdul Rashid; Ka-Liong Tan; Chuei Wuei Leong
Journal:  J Curr Glaucoma Pract       Date:  2021 Sep-Dec

8.  Preliminary evaluations of 3-dimensional human skin models for their ability to facilitate in vitro the long-term development of the debilitating obligatory human parasite Onchocerca volvulus.

Authors:  Christoph Malkmus; Shabnam Jawahar; Nancy Tricoche; Sara Lustigman; Jan Hansmann
Journal:  PLoS Negl Trop Dis       Date:  2020-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.